Cargando…
Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis
The factors influencing long-term responses to a tumor necrosis factor inhibitor (TNFi) in rheumatoid arthritis (RA) patients currently remain unknown. Therefore, we herein conducted a multi-omics analysis of TNFi responses in a Japanese RA cohort. Blood samples were collected from 27 biological dis...
Autores principales: | Iwasaki, Takeshi, Watanabe, Ryu, Ito, Hiromu, Fujii, Takayuki, Okuma, Kenji, Oku, Takuma, Hirayama, Yoshitaka, Ohmura, Koichiro, Murata, Koichi, Murakami, Kosaku, Yoshitomi, Hiroyuki, Tanaka, Masao, Matsuda, Shuichi, Matsuda, Fumihiko, Morinobu, Akio, Hashimoto, Motomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208293/ https://www.ncbi.nlm.nih.gov/pubmed/35734167 http://dx.doi.org/10.3389/fimmu.2022.901437 |
Ejemplares similares
-
How do symptoms of each joint contribute to global pain, disease activity and functional disability in rheumatoid arthritis?—A comprehensive association study using a large cohort
por: Umemoto, Akio, et al.
Publicado: (2023) -
Expression of S100A8 protein on B cells is associated with disease activity in patients with systemic lupus erythematosus
por: Kitagori, Koji, et al.
Publicado: (2023) -
Urinary sodium-to-potassium ratio associates with hypertension and current disease activity in patients with rheumatoid arthritis: a cross-sectional study
por: Minamino, Hiroto, et al.
Publicado: (2021) -
Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort
por: Murata, Koichi, et al.
Publicado: (2020) -
Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis
por: Umemoto, Akio, et al.
Publicado: (2023)